An overview of triple-negative breast cancer
P Kumar, R Aggarwal - Archives of gynecology and obstetrics, 2016 - Springer
Purpose Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors
comprising various breast cancers simply defined by the absence of estrogen receptor …
comprising various breast cancers simply defined by the absence of estrogen receptor …
Targeting angiogenesis in breast cancer: current evidence and future perspectives of novel anti-angiogenic approaches
NM Ayoub, SK Jaradat, KM Al-Shami… - Frontiers in …, 2022 - frontiersin.org
Angiogenesis is a vital process for the growth and dissemination of solid cancers. Numerous
molecular pathways are known to drive angiogenic switch in cancer cells promoting the …
molecular pathways are known to drive angiogenic switch in cancer cells promoting the …
Single-breath-hold photoacoustic computed tomography of the breast
We have developed a single-breath-hold photoacoustic computed tomography (SBH-PACT)
system to reveal detailed angiographic structures in human breasts. SBH-PACT features a …
system to reveal detailed angiographic structures in human breasts. SBH-PACT features a …
[HTML][HTML] Contribution of adipose tissue to development of cancer
AJ Cozzo, AM Fuller, L Makowski - Comprehensive Physiology, 2017 - ncbi.nlm.nih.gov
Solid tumor growth and metastasis require the interaction of tumor cells with the surrounding
tissue, leading to a view of tumors as tissue-level phenomena rather than exclusively cell …
tissue, leading to a view of tumors as tissue-level phenomena rather than exclusively cell …
The Current Status of Breast MR Imaging Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice1
C Kuhl - Radiology, 2007 - pubs.rsna.org
Compared with mammography and breast ultrasonography, contrast material–enhanced
magnetic resonance (MR) imaging is a breast imaging technique that offers not only …
magnetic resonance (MR) imaging is a breast imaging technique that offers not only …
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies
T Shih, C Lindley - Clinical therapeutics, 2006 - Elsevier
BACKGROUND:: Bevacizumab is a recombinant humanized monoclonal antibody that was
approved by the US Food and Drug Administration (FDA) in February 2004 for use as part of …
approved by the US Food and Drug Administration (FDA) in February 2004 for use as part of …
Targeting endothelial permeability in the EPR effect
The characteristics of the primary tumor blood vessels and the tumor microenvironment drive
the enhanced permeability and retention (EPR) effect, which confers an advantage towards …
the enhanced permeability and retention (EPR) effect, which confers an advantage towards …
[HTML][HTML] Emerging targeted therapies in triple-negative breast cancer
J Crown, J O'shaughnessy, G Gullo - Annals of oncology, 2012 - Elsevier
Standard chemotherapy regimens can prove effective for patients with early triple-negative
breast cancer (TNBC); however, patients with advanced disease typically respond poorly …
breast cancer (TNBC); however, patients with advanced disease typically respond poorly …
A green synthesis of carbon nanoparticles from honey and their use in real-time photoacoustic imaging
Imaging sentinel lymph nodes (SLN) could provide us with critical information about the
progression of a cancerous disease. Real-time high-resolution intraoperative photoacoustic …
progression of a cancerous disease. Real-time high-resolution intraoperative photoacoustic …
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions
A Morabito, E De Maio, M Di Maio, N Normanno… - The …, 2006 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the mechanism of action of tyrosine kinase inhibitors of VEGFRs that are in clinical trials …
the mechanism of action of tyrosine kinase inhibitors of VEGFRs that are in clinical trials …